Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 An Inoperable Cancer, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13b-0501. Case and Commentary Jan 2005 An Inoperable Cancer, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):68-73. doi: 10.1001/virtualmentor.2005.7.1.ccas13c-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14a-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Option Assessment Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15a-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions Option Comparison Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15b-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Additional Information Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15c-0501. In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Pagination First page « First Previous page ‹ Previous … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 Next page Next › Last page Last »
Case and Commentary Jan 2005 An Inoperable Cancer, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13b-0501.
Case and Commentary Jan 2005 An Inoperable Cancer, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):68-73. doi: 10.1001/virtualmentor.2005.7.1.ccas13c-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14a-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Option Assessment Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15a-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions Option Comparison Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15b-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Additional Information Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15c-0501.
In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.